Search
for
Sort by
Research 781–810 of 1000+
- Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID
- Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation
- Improved Humoral Immunity and Protection against Influenza Virus Infection with a 3d Porous Biomaterial Vaccine
- Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service
- Long COVID? What is that?
- Single-cell transcriptomics reveals the natural product Shi-Bi-Man promotes hair regeneration by activating the FGF pathway in dermal papilla cells
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- The COVID-19 pandemic and its skin effects
- Beyond ECMO Survival: Long-Term Symptom Burden and Quality-of-Life Impairment in Hantavirus Cardiopulmonary Syndrome Survivors
- Bibliometric Analysis of Research Trends and Prospective Directions of Lung Microbiome
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
- Cutaneous Manifestations of COVID-19
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses
- Unraveling Evolutionary Insights into AVT Peptide Conservation and Antimicrobial Motif Prediction Across Taxa
- Knowledge, Attitude, and Practice Regarding COVID-19 Skin Manifestations among Doctors Working at Khartoum Dermatology and Venereology Teaching Hospital, 2021
- Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19.
- Post-covid-19 hair loss syndrome
- Efluvio telógeno: uma sequela pos-COVID 19
- [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
- Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
- Bacillus Calmette-Guerin (BCG) Site Reaction After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
- Covid-19, Diagnostic History and Mortality from Medicare 1999-2021, In an All-Cause Mortality Approach
- Hair loss following COVID-19 infection - the state of current knowledge and treatment approaches.
- Efluvio telógeno y Covid-19